SBFM logo

Sunshine Biopharma (SBFM) Cash From Operations

Annual CFO

-$8.78 M
-$3.53 M-67.20%

December 31, 2023

Summary

Performance

1-Year Change

-67.2%

3-Year Change

-1235.02%

5-Year Change

-1611.21%

15-Year Change

-1514.55%

SBFM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

62.26%
SBFM annual cash flow from operations is higher than 62.26% of companies in Healthcare sector

High & Low

All-time High

-$3100.00

3-Year Low

-$8.78 M
SBFM annual cash flow from operations is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SBFM previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 20, 2025
SBFM next annual earnings announcement is scheduled for May 20, 2025

OtherSBFMcash flowmetrics:

Annual CFI

-$656.20 K
SBFM annual cash flow from investing activities is -$656.20 thousand

Annual CFF

$3.43 M
SBFM annual cash flow from financing activities is $3.43 million

Annual FCF

-$9.56 M
SBFM annual free cash flow is -$9.56 million

Annual CAPEX

$788.10 K
SBFM annual capital expenditures is $788.10 thousand

Quarterly CFO

-$1.36 M
+$3.22 M+70.27%

September 30, 2024

Summary

Performance

3-Month Change

+70.27%

1-Year Change

-197.62%

3-Year Change

+63.98%

5-Year Change

+63.98%

SBFM Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

64.69%
SBFM quarterly cash flow from operations is higher than 64.69% of companies in Healthcare sector

High & Low

All-time High

$1.19 M
SBFM quarterly cash flow from operations is currently -214.53% below its historical high of $1.19 million

3-Year Low

-$4.58 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SBFM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 20, 2025
SBFM next earnings announcement is scheduled for May 20, 2025

OtherSBFMcash flowmetrics:

Quarterly CFI

-$578.40 K
SBFM quarterly cash flow from investing activities is -$578.40 thousand

Quarterly CFF

$1.87 M
SBFM quarterly cash flow from financing activities is $1.87 million

Quarterly FCF

-$1.97 M
SBFM quarterly free cash flow is -$1.97 million

Quarterly CAPEX

$609.50 K
SBFM quarterly capital expenditures is $609.50 thousand

TTM CFO

-$11.81 M
-$903.70 K-8.28%

September 30, 2024

Summary

Performance

3-Month Change

-8.28%

1-Year Change

-41.79%

3-Year Change

-31.29%

5-Year Change

-31.29%

SBFM TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

55.93%
SBFM TTM cash flow from operations is higher than 55.93% of companies in Healthcare sector

High & Low

All-time High

$891.50 K
SBFM TTM cash flow from operations is currently -1425.15% below its historical high of $891.50 thousand

3-Year Low

-$11.81 M
SBFM TTM cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SBFM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 20, 2025
SBFM next earnings announcement is scheduled for May 20, 2025

OtherSBFMcash flowmetrics:

TTM CFI

-$2.06 M
SBFM TTM cash flow from investing activities is -$2.06 million

TTM CFF

$7.21 M
SBFM TTM cash flow from financing activities is $7.21 million

TTM FCF

-$14.00 M
SBFM TTM free cash flow is -$14.00 million

TTM CAPEX

$2.19 M
SBFM TTM capital expenditures is $2.19 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

SBFM Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-67.2%-197.6%-41.8%
3 y3 years-1235.0%+64.0%-31.3%
5 y5 years-1611.2%+64.0%-31.3%

SBFM Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-379.8%at low-336.1%+70.3%-545.8%at low
5 y5-year-1669.9%at low-4290.3%+70.3%-3934.7%at low
alltimeall time<-9999.0%at low-214.5%+70.3%-1425.2%at low

Sunshine Biopharma Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.36 M(-70.3%)
-$11.81 M(+8.3%)
Jun 2024
-
-$4.58 M(+43.7%)
-$10.91 M(+7.9%)
Mar 2024
-
-$3.19 M(+18.4%)
-$10.11 M(+15.2%)
Dec 2023
-$8.78 M(+67.2%)
-$2.69 M(+488.2%)
-$8.78 M(+5.3%)
Sep 2023
-
-$457.30 K(-87.9%)
-$8.33 M(-7.4%)
Jun 2023
-
-$3.78 M(+104.2%)
-$9.00 M(+55.3%)
Mar 2023
-
-$1.85 M(-17.6%)
-$5.79 M(+10.4%)
Dec 2022
-$5.25 M(+186.9%)
-$2.25 M(+99.9%)
-$5.25 M(+58.4%)
Sep 2022
-
-$1.12 M(+95.8%)
-$3.31 M(+18.7%)
Jun 2022
-
-$573.80 K(-56.0%)
-$2.79 M(-1.6%)
Mar 2022
-
-$1.30 M(+317.9%)
-$2.84 M(+55.0%)
Dec 2021
-$1.83 M(+178.3%)
-
-
Dec 2021
-
-$312.10 K(-48.1%)
-$1.83 M(-5.8%)
Sep 2021
-
-$600.80 K(-2.9%)
-$1.94 M(+32.9%)
Jun 2021
-
-$618.90 K(+108.1%)
-$1.46 M(+58.1%)
Mar 2021
-
-$297.40 K(-29.8%)
-$923.70 K(+40.5%)
Dec 2020
-$657.30 K(+32.6%)
-$423.70 K(+251.3%)
-$657.30 K(+81.9%)
Sep 2020
-
-$120.60 K(+47.1%)
-$361.40 K(+10.4%)
Jun 2020
-
-$82.00 K(+164.5%)
-$327.30 K(+11.8%)
Mar 2020
-
-$31.00 K(-75.7%)
-$292.80 K(-40.9%)
Dec 2019
-$495.80 K(-3.3%)
-$127.80 K(+47.7%)
-$495.80 K(+2.4%)
Sep 2019
-
-$86.50 K(+82.1%)
-$484.00 K(-14.8%)
Jun 2019
-
-$47.50 K(-79.7%)
-$568.40 K(-1.7%)
Mar 2019
-
-$234.00 K(+101.7%)
-$578.30 K(+12.8%)
Dec 2018
-$512.80 K(-5.6%)
-$116.00 K(-32.1%)
-$512.80 K(-15.4%)
Sep 2018
-
-$170.90 K(+197.7%)
-$606.30 K(+3.9%)
Jun 2018
-
-$57.40 K(-65.9%)
-$583.60 K(-3.4%)
Mar 2018
-
-$168.50 K(-19.6%)
-$604.00 K(+11.1%)
Dec 2017
-$543.50 K(+73.0%)
-$209.50 K(+41.4%)
-$543.50 K(+48.8%)
Sep 2017
-
-$148.20 K(+90.5%)
-$365.20 K(+30.4%)
Jun 2017
-
-$77.80 K(-28.0%)
-$280.00 K(-17.8%)
Mar 2017
-
-$108.00 K(+246.2%)
-$340.60 K(+8.4%)
Dec 2016
-$314.20 K
-$31.20 K(-50.5%)
-$314.20 K(-49.8%)
Sep 2016
-
-$63.00 K(-54.5%)
-$625.80 K(-6.0%)
Jun 2016
-
-$138.40 K(+69.6%)
-$665.40 K(-20.4%)
DateAnnualQuarterlyTTM
Mar 2016
-
-$81.60 K(-76.2%)
-$836.20 K(-3.6%)
Dec 2015
-$867.60 K(+61.1%)
-$342.80 K(+234.1%)
-$867.60 K(+12.3%)
Sep 2015
-
-$102.60 K(-66.8%)
-$772.50 K(+12.3%)
Jun 2015
-
-$309.20 K(+173.6%)
-$688.00 K(+22.7%)
Mar 2015
-
-$113.00 K(-54.4%)
-$560.80 K(+4.1%)
Dec 2014
-$538.60 K(-4.6%)
-$247.70 K(+1268.5%)
-$538.60 K(+62.9%)
Sep 2014
-
-$18.10 K(-90.1%)
-$330.60 K(-17.0%)
Jun 2014
-
-$182.00 K(+100.4%)
-$398.10 K(+26.2%)
Mar 2014
-
-$90.80 K(+128.7%)
-$315.40 K(-44.1%)
Dec 2013
-$564.40 K(+43.6%)
-$39.70 K(-53.6%)
-$564.30 K(-19.1%)
Sep 2013
-
-$85.60 K(-13.8%)
-$697.40 K(-9.7%)
Jun 2013
-
-$99.30 K(-70.8%)
-$772.10 K(+10.6%)
Mar 2013
-
-$339.70 K(+96.6%)
-$698.00 K(+77.6%)
Dec 2012
-$393.10 K(+32.2%)
-$172.80 K(+7.8%)
-$393.10 K(+16.3%)
Sep 2012
-
-$160.30 K(+536.1%)
-$338.10 K(+14.1%)
Jun 2012
-
-$25.20 K(-27.6%)
-$296.20 K(+2.9%)
Mar 2012
-
-$34.80 K(-70.5%)
-$287.80 K(-3.2%)
Dec 2011
-$297.30 K(-14.6%)
-$117.80 K(-0.5%)
-$297.30 K(-29.9%)
Sep 2011
-
-$118.40 K(+604.8%)
-$423.90 K(+35.2%)
Jun 2011
-
-$16.80 K(-62.1%)
-$313.60 K(-135.2%)
Mar 2011
-
-$44.30 K(-81.9%)
$891.50 K(-356.0%)
Dec 2010
-$348.30 K(-35.1%)
-$244.40 K(+2917.3%)
-$348.30 K(+235.2%)
Sep 2010
-
-$8100.00(-100.7%)
-$103.90 K(-81.6%)
Jun 2010
-
$1.19 M(-192.5%)
-$565.00 K(-67.8%)
Mar 2010
-
-$1.28 M(+173.7%)
-$1.75 M(+270.6%)
Dec 2009
-$536.90 K(+5163.7%)
-
-
Oct 2009
-
-$469.20 K(>+9900.0%)
-$473.50 K(+4542.2%)
Jul 2009
-$10.20 K(-55.7%)
-$1500.00(-21.1%)
-$10.20 K(-8.9%)
Apr 2009
-
-$1900.00(+111.1%)
-$11.20 K(-43.4%)
Jan 2009
-
-$900.00(-84.7%)
-$19.80 K(-9.6%)
Oct 2008
-
-$5900.00(+136.0%)
-$21.90 K(-4.8%)
Jul 2008
-$23.00 K(+641.9%)
-$2500.00(-76.2%)
-$23.00 K(+12.2%)
Apr 2008
-
-$10.50 K(+250.0%)
-$20.50 K(+105.0%)
Jan 2008
-
-$3000.00(-57.1%)
-$10.00 K(+42.9%)
Oct 2007
-
-$7000.00
-$7000.00
Jul 2007
-$3100.00
-
-

FAQ

  • What is Sunshine Biopharma annual cash flow from operations?
  • What is the all time high annual CFO for Sunshine Biopharma?
  • What is Sunshine Biopharma annual CFO year-on-year change?
  • What is Sunshine Biopharma quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Sunshine Biopharma?
  • What is Sunshine Biopharma quarterly CFO year-on-year change?
  • What is Sunshine Biopharma TTM cash flow from operations?
  • What is the all time high TTM CFO for Sunshine Biopharma?
  • What is Sunshine Biopharma TTM CFO year-on-year change?

What is Sunshine Biopharma annual cash flow from operations?

The current annual CFO of SBFM is -$8.78 M

What is the all time high annual CFO for Sunshine Biopharma?

Sunshine Biopharma all-time high annual cash flow from operations is -$3100.00

What is Sunshine Biopharma annual CFO year-on-year change?

Over the past year, SBFM annual cash flow from operations has changed by -$3.53 M (-67.20%)

What is Sunshine Biopharma quarterly cash flow from operations?

The current quarterly CFO of SBFM is -$1.36 M

What is the all time high quarterly CFO for Sunshine Biopharma?

Sunshine Biopharma all-time high quarterly cash flow from operations is $1.19 M

What is Sunshine Biopharma quarterly CFO year-on-year change?

Over the past year, SBFM quarterly cash flow from operations has changed by -$903.70 K (-197.62%)

What is Sunshine Biopharma TTM cash flow from operations?

The current TTM CFO of SBFM is -$11.81 M

What is the all time high TTM CFO for Sunshine Biopharma?

Sunshine Biopharma all-time high TTM cash flow from operations is $891.50 K

What is Sunshine Biopharma TTM CFO year-on-year change?

Over the past year, SBFM TTM cash flow from operations has changed by -$3.48 M (-41.79%)